Skip to main content

Advertisement

Log in

Secondary Hyperparathyroidism Before and After Bariatric Surgery: a Prospective Study with 2-Year Follow-Up

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Purpose

Secondary hyperparathyroidism (SHPT) is linked to obesity. Bariatric surgery may be associated with calcium and vitamin D deficiencies leading to SHPT. This study aimed to detect the prevalence of SHPT before and after bariatric surgery.

Methods

This prospective study assessed the prevalence of SHPT after sleeve gastrectomy (SG, n = 38) compared to one-anastomosis gastric bypass (OAGB, n = 86). All patients were followed up for 2 years. Bone mineral density (BMD) was assessed using dual-energy X-ray absorptiometry.

Results

Of the 124 patients, 71 (57.3%) were females, and 53 (42.7%) were males, with a mean age of 37.5 ± 8.8 years. Before surgery, 23 patients (18.5%) suffered from SHPT, and 40 (32.3%) had vitamin D deficiency. The prevalence of SHPT increased to 29.8% after 1 year and 36.3% after 2 years. SHPT was associated with lower levels of vitamin D and calcium and higher reduction of BMD in the hip but not in the spine. After 2 years, SHPT was associated with a significantly lower T-score in the hip. SHPT and vitamin D deficiency were significantly more common in patients subjected to OAGB compared to SG (p = 0.003, and p < 0.001, respectively). There is a strong negative correlation between vitamin D levels and parathormone levels before and after surgery.

Conclusion

Prevalence of SHPT is high in obese patients seeking bariatric surgery, especially with lower vitamin D levels. Bariatric surgery increases the prevalence of SHPT up to 2 years. Gastric bypass is associated with a higher risk of developing SHPT compared to SG.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15:288–98

    Article  Google Scholar 

  2. Aboulghate M, Elaghoury A, Elebrashy I, Elkafrawy N, Elshishiney G, Abul-Magd E, et al. The burden of obesity in Egypt. Front Public Health. 2021;9:1247

    Article  Google Scholar 

  3. Bray GA, Kim KK, Wilding JPH. World obesity federation. Obesity: a chronic relapsing progressive disease process. A position statement of the world obesity federation. Obes Rev. 2017;18:715–23

    Article  CAS  Google Scholar 

  4. Saab G, Whaley-Connell A, McFarlane SI, Li S, Chen S-C, Sowers JR, et al. Obesity is associated with increased parathyroid hormone levels independent of glomerular filtration rate in chronic kidney disease. Metabolism. 2010;59:385–9

    Article  CAS  Google Scholar 

  5. Goldner WS, Stoner JA, Thompson J, Taylor K, Larson L, Erickson J, et al. Prevalence of vitamin D insufficiency and deficiency in morbidly obese patients: a comparison with non-obese controls. Obes Surg. 2008;18:145–50

    Article  Google Scholar 

  6. Rodríguez-Rodríguez E, Navia B, López-Sobaler AM, Ortega RM. Vitamin D in overweight/obese women and its relationship with dietetic and anthropometric variables. Obesity. 2009;17:778–82

    Article  Google Scholar 

  7. Guasch A, Bulló M, Rabassa A, Bonada A, Del Castillo D, Sabench F, et al. Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study. Cardiovasc Diabetol. 2012;11:149

    Article  CAS  Google Scholar 

  8. Wiggins T, Guidozzi N, Welbourn R, Ahmed AR, Markar SR. Association of bariatric surgery with all-cause mortality and incidence of obesity-related disease at a population level: a systematic review and meta-analysis. PLoS Med. 2020;17:e1003206

    Article  Google Scholar 

  9. O’Brien PE, Hindle A, Brennan L, Skinner S, Burton P, Smith A, et al. Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-Centre review of 20-year outcomes after adjustable gastric banding. Obes Surg. 2019;29:3–14

    Article  Google Scholar 

  10. Suthakaran R, Indigahawela I, Mori K, Lim K, Aly A. Preventing calcium and vitamin D deficiencies following weight loss and metabolic surgery. BMC Surg. 2021;21:351

    Article  CAS  Google Scholar 

  11. Rousseau C, Jean S, Gamache P, Lebel S, Mac-Way F, Biertho L, et al. Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study. BMJ. British Medical Journal Publishing Group; 2016;354:i3794.

  12. Holick MF. Vitamin D status: measurement, interpretation and clinical application. Ann Epidemiol. 2009;19:73–8

    Article  Google Scholar 

  13. Nissenson RA, Jüppner H. Parathyroid hormone. Primer on the metabolic bone diseases and disorders of mineral metabolism [Internet]. John Wiley & Sons, Ltd; [cited 2021 Sep 30]. p. 208–14. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/9781118453926.ch26

  14. Cunningham J, Locatelli F, Rodriguez M. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. CJASN Am Soc Nephrol. 2011;6:913–21

    Article  CAS  Google Scholar 

  15. Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ, Khaltaev N. A reference standard for the description of osteoporosis. Bone. 2008;42:467–75

    Article  CAS  Google Scholar 

  16. Wei J-H, Lee W-J, Chong K, Lee Y-C, Chen S-C, Huang P-H, et al. High incidence of secondary hyperparathyroidism in bariatric patients: comparing different procedures. Obes Surg. 2018;28:798–804

    Article  Google Scholar 

  17. Mendonça FM, Neves JS, Silva MM, Borges-Canha M, Costa C, Cabral PM, et al. Secondary hyperparathyroidism among bariatric patients: unraveling the prevalence of an overlooked foe. Obes Surg. 2021;31:3768–75

    Article  Google Scholar 

  18. Alejo Ramos M, Cano Rodríguez IM, Urioste Fondo AM, Pintor de la Maza B, Barajas Galindo DE, Fernández Martínez P, et al. Secondary hyperparathyroidism in patients with biliopancreatic diversion after 10 years of follow-up, and relationship with vitamin D and serum calcium. Obes Surg. 2019;29:999–1006

    Article  Google Scholar 

  19. Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL, et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham heart study. Diabetes. 2010;59:242–8

    Article  CAS  Google Scholar 

  20. Yetley EA. Assessing the vitamin D status of the US population. Am J Clin Nutr. 2008;88:558S–64S

    Article  CAS  Google Scholar 

  21. Mousa A, Naderpoor N, de Courten MPJ, Scragg R, de Courten B. 25-hydroxyvitamin D is associated with adiposity and cardiometabolic risk factors in a predominantly vitamin D-deficient and overweight/obese but otherwise healthy cohort. J Steroid Biochem Mol Biol. 2017;173:258–64

    Article  CAS  Google Scholar 

  22. Karuppusami R, Antonisami B, Vasan SK, Gowri M, Selliah HY, Arulappan G, et al. Association of serum 25-hydroxy vitamin D with total and regional adiposity and cardiometabolic traits. PLOS ONE. Public library of Science; 2020;15:e0243850.

  23. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72:690–3

    Article  CAS  Google Scholar 

  24. Drincic AT, Armas LAG, Van Diest EE, Heaney RP. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring). 2012;20:1444–8

    Article  CAS  Google Scholar 

  25. Wamberg L, Christiansen T, Paulsen SK, Fisker S, Rask P, Rejnmark L, et al. Expression of vitamin D-metabolizing enzymes in human adipose tissue -- the effect of obesity and diet-induced weight loss. Int J Obes 2013;37:651–657.

  26. Peterson LA. Bariatric surgery and vitamin D: key messages for surgeons and clinicians before and after bariatric surgery. Minerva Chir. 2016;71:322–36

    PubMed  Google Scholar 

  27. Chakhtoura M, Nakhoul N, Shawwa K, Mantzoros C, El Hajj FG. Hypovitaminosis D in bariatric surgery: a systematic review of observational studies. Metabolism. 2016;65:574–85

    Article  CAS  Google Scholar 

  28. Dogan K, Homan J, Aarts EO, de Boer H, van Laarhoven CJHM, Berends FJ. Long-term nutritional status in patients following roux-en-Y gastric bypass surgery. Clin Nutr. 2018;37:612–7

    Article  Google Scholar 

  29. Arias PM, Domeniconi EA, García M, Esquivel CM, Martínez Lascano F, Foscarini JM. Micronutrient deficiencies after roux-en-Y gastric bypass: long-term results. Obes Surg. 2020;30:169–73

    Article  Google Scholar 

  30. Schafer AL, Weaver CM, Black DM, Wheeler AL, Chang H, Szefc GV, et al. Intestinal calcium absorption decreases dramatically after gastric bypass surgery despite optimization of vitamin D status. J Bone Miner Res. 2015;30:1377–85

    Article  CAS  Google Scholar 

  31. Carrasco F, Basfi-fer K, Rojas P, Csendes A, Papapietro K, Codoceo J, et al. Calcium absorption may be affected after either sleeve gastrectomy or roux-en-Y gastric bypass in premenopausal women: a 2-y prospective study. Am J Clin Nutr. 2018;108:24–32

    Article  Google Scholar 

  32. Braghetto I, Davanzo C, Korn O, Csendes A, Valladares H, Herrera E, et al. Scintigraphic evaluation of gastric emptying in obese patients submitted to sleeve gastrectomy compared to normal subjects. Obes Surg. 2009;19:1515–21

    Article  Google Scholar 

  33. Schafer AL. Vitamin D and intestinal calcium transport after bariatric surgery. J Steroid Biochem Mol Biol. 2017;173:202–10

    Article  CAS  Google Scholar 

  34. Fleet JC, Schoch RD. Molecular mechanisms for regulation of intestinal calcium absorption by vitamin D and other factors. Crit Rev Clin Lab Sci. 2010;47:181–95

    Article  CAS  Google Scholar 

  35. Altawil E, Alkofide H, Alamri H, Alhassan N, Alsubaie H, Alqahtani A, et al. Secondary hyperparathyroidism in obese patients post sleeve gastrectomy. DMSO Dove Press. 2021;14:4059–66

    Article  Google Scholar 

  36. Jalali SM, Azadbakht M, Azadbakht S, Daniali S, Farokhi E. Prevalence of secondary hyperparathyroidism following bariatric surgery. International Journal of Surgery Open. 2020;27:214–9

    Article  Google Scholar 

  37. Jaruvongvanich V, Vantanasiri K, Upala S, Ungprasert P. Changes in bone mineral density and bone metabolism after sleeve gastrectomy: a systematic review and meta-analysis. Surg Obes Relat Dis. 2019;15:1252–60

    Article  Google Scholar 

  38. Liu C, Wu D, Zhang J-F, Xu D, Xu W-F, Chen Y, et al. Changes in bone metabolism in morbidly obese patients after bariatric surgery: a meta-analysis. Obes Surg. 2016;26:91–7

    Article  Google Scholar 

  39. de Holanda NCP, Baad VMA, Bezerra LR, de Lima SKM, Filho JM, de Holanda Limeira CC, et al. Secondary hyperparathyroidism, bone density, and bone turnover after bariatric surgery: differences between roux-en-Y gastric bypass and sleeve gastrectomy. Obes Surg. 2021;

  40. Maghrabi AH, Wolski K, Abood B, Licata A, Pothier C, Bhatt DL, et al. Two-year outcomes on bone density and fracture incidence in patients with T2DM randomized to bariatric surgery versus intensive medical therapy. Obesity (Silver Spring). 2015;23:2344–8

    Article  Google Scholar 

  41. Blom-Høgestøl IK, Hewitt S, Chahal-Kummen M, Brunborg C, Gulseth HL, Kristinsson JA, et al. Bone metabolism, bone mineral density and low-energy fractures 10 years after roux-en-Y gastric bypass. Bone. 2019;127:436–45

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohamed AbdAlla Salman.

Ethics declarations

Ethics Approval

All performed procedures were in accordance with the ethical standards of the institutional research committee and with the Helsinki declaration.

Informed Consent

Informed consent was obtained from all patients included in this study.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Key Points

• Prevalence of SHPT is high in obese patients seeking bariatric surgery.

• Bariatric surgery increases the prevalence of SHPT up to 2 years.

• Gastric bypass is associated with a higher risk of developing SHPT compared to SG.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Salman, M.A., Salman, A., Elewa, A. et al. Secondary Hyperparathyroidism Before and After Bariatric Surgery: a Prospective Study with 2-Year Follow-Up. OBES SURG 32, 1141–1148 (2022). https://doi.org/10.1007/s11695-022-05902-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-022-05902-7

Keywords

Navigation